The stock of National Veterinary Care Ltd (ASX:NVL) is a huge mover today! The stock increased 4.29% or $0.09 on November 18, hitting $2.19. About 30,252 shares traded hands. National Veterinary Care Ltd (ASX:NVL) has risen 58.70% since April 22, 2016 and is uptrending. It has outperformed by 54.27% the S&P500.
The move comes after 8 months positive chart setup for the $101.25M company. It was reported on Nov, 18 by Barchart.com. We have $6.00 PT which if reached, will make ASX:NVL worth $176.18 million more.
More notable recent National Veterinary Care Ltd (ASX:NVL) news were published by: Smh.com.Au which released: “National Vet Care no dog in first day of trading” on August 14, 2015, also Fool.com.Au with their article: “What to expect when National Veterinary Care Ltd launches tomorrow” published on August 13, 2015, Smh.com.Au published: “National Vet Care to dog Greencross’s steps” on June 14, 2015. More interesting news about National Veterinary Care Ltd (ASX:NVL) were released by: Fool.com.Au and their article: “A first look at the National Vet Care IPO” published on June 26, 2015 as well as Fool.com.Au‘s news article titled: “Could National Vet Care be an IPO worth backing?” with publication date: June 18, 2015.
National Veterinary Care Ltd is engaged in the provision of veterinary services throughout Australia. The company has a market cap of $101.25 million. The Company’s network of veterinary clinics offer various services, including acupuncture, blood tests, chemotherapy, dental radiography, desexing, digital radiography , electrocardiograph (ECG), heartworm injections, health exams, healthy nutrition programs, in-house pathology, intensive care hospitalization, microchip identification, nail trimming, orthopedic surgery, senior and palliative care, stem cell therapy, ultrasounds, vaccinations and weight loss programs. It has a 103.01 P/E ratio. The Company’s Best for Pet service provides optimal healthcare for pet.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.